Searchable abstracts of presentations at key conferences in endocrinology

ea0037oc6.3 | Thyroid | ECE2015

Different TSH suppressive effects of liothyronine combination according to Thr92Ala type 2 deiodinase polymorphism

Shin Dong Yeob , Kim Kwang Joon , An Jiyean , Lee Eun Jig

Introduction: Type 2 deiodinase (D2) catalyses intracellular T3 production in several human tissues including pituitary gland, hence occupying an important role in the feedback regulation of TSH secretion. Although several previous researches have shown that Thr92Ala D2 polymorphism with decreased D2 enzymatic activity influences the levothyroxine dose requirement and the set point of the hypothalamus–pituitary–thyroid axis for postoperative TSH suppressiv...

ea0065p281 | Neuroendocrinology | SFEBES2019

Clinical PhenClinical phenotypes of GNAS gene mutations in Korean Acromegalic Patientsotypes of GNAS gene mutations in Korean acromegalic patients

Ku Cheol Ryong , Jung Hyein , Kim Kyungwon , Kim Daham , Lee Eun Jig

Background: Guanine nucleotide-binding protein, α stimulating (GNAS) gene have been reported to be associated with GH secreting pituitary adenoma. Approximately 40% of patients with acromegaly have GNAS mutation. In this study, we investigated the prevalence of GNAS mutation in Korean acromegalic patients and assessed the correlation with the biochemical or clinical characteristics.Method: We studied acromegalic patients who underwent surgery betwee...

ea0037ep787 | Pituitary: clinical | ECE2015

The effect of pregnancy and lactation on prolactinoma

Kim Wonjin , Ku Cheol Ryong , Hong Jae Won , Lee Eun Jig

Prolactinoma predominantly occurred in young women of reproductive age. But there are limited data about the effect of pregnancy and lactation on prolactinoma progression. We evaluated the safety of dopamine agonists including bromocriptine and cabergoline and pregnancy outcome in prolactinoma patients. Patients diagnosed with prolactinoma who experienced pregnancies were included. Sellar MRI and serum prolactin levels were performed before and after pregnancy and lactation. T...

ea0049ep960 | Pituitary - Clinical | ECE2017

Prevalence and Incidence of pituitary tumors: a nation-wide Population-based study using Korean National Health Insurance claims data

Park Kyeonghye , Choi Junggyu , Park Se Hee , Nam Joo Young , Song Sun Ok , Song Young Duk , Lee Eun Jig

Purpose: We conducted this study to determine the prevalence and incidence of pituitary tumors in South Korea.Methods: This is a nationwide population- based retrospective study. We analysed two national databases, the Korean National Health Insurance (NHI) claims database and Rare Intractable Disease (RID) registration database, which include information on every patients with pituitary tumor diagnosed through uniform criteria from 2009 to 2013. Pituita...

ea0056gp111 | Diabetes Translational | ECE2018

Olfactory receptor OR51E1 mediates GLP-1 secretion in enteroendocrine L cells

Ku Cheol Ryong , Han Ye Eon , Kim Daham , Hong Jae Won , Kim Sun Ho , Lee Eun Jig

Few studies have investigated the intracellular signaling pathways mediating the effects of glucagon-like peptide-1 (GLP-1) secretagogues in enteroendocrine L cells. Specific receptors, channels, and intracellular signaling proteins expressed by the L cells have only begun to be characterized. The present study aimed to investigate the role of the olfactory receptor (OR) OR51E1 in GLP-1 secretion. We verified the expression of olfactory marker protein (OMP), an indicator of OR...

ea0056gp194 | Pituitary Basic | ECE2018

Olfactory marker protein regulates prolactin secretion and production by modulating Ca2+ and TRH signaling in lactotrophs

Ku Cheol Ryong , Kang Chan Woo , Kim Daham , Hong Jae Won , Kim Sun Ho , Lee Eun Jig

Olfactory marker protein (OMP) is a marker of olfactory receptor-mediated chemoreception, even outside the olfactory system. Here, we report that OMP expression in the pituitary gland plays a role in basal and thyrotropin-releasing hormone (TRH)-induced prolactin (PRL) production and secretion. We found that OMP was expressed in human and rodent pituitary glands, especially in PRL-secreting lactotrophs. OMP knockdown in GH4 rat pituitary cells increased PRL production and secr...

ea0056p806 | Pituitary - Clinical | ECE2018

Association between prolactin level and tumor size reduction at 3 months after cabergoline treatment in patients with macroprolactinoma

Kim Daham , Lee Youngki , Park Se Hee , Park Kyeong Hye , Ryong Ku Cheol , Kim Sun Ho , Lee Eun Jig

Objectives: Prolactin (PRL) normalization after 3 months of Cabergoline (CAB) treatment are useful predictors of responsiveness in patients with prolactinoma. However, differences within the PRL normalization cut-off value have not been identified.Methods: We reviewed the medical records of patients with prolactinomas who were treated with CAB as a primary drug at Severance Hospital. We included patients who had a full dataset of pituitary hormone assays...

ea0056gp73 | Diabetes Complications | ECE2018

The BMI and skeletal muscle mass as a risk factor of carotid atherosclerosis in patients with type 2 diabetes

Kim Se-Hwa , Kim Soo-Kyung , Choi Young-Ju , Park Seok-Won , Lee Eun-Jig , Cho Yong-Wook , Huh Kap-Bum

Background: The body mass index (BMI) is the most widely used method of assessing fat accumulation, and is recognized as an independent risk factor for cardiometabolic diseases. However, there might be substantial variations in the fat or muscle amount among persons with a similar BMI. The aim of the present study was to investigate whether BMI and skeletal muscle mass (SMM) estimated from by bioelectrical impedance analysis (BIA) are associated with carotid atherosclerosis in...

ea0056p809 | Pituitary - Clinical | ECE2018

Clinical parameters to distinguish silent corticotroph adenomas from other non-functioning pituitary adenomas

Kim Daham , Ku Cheol Ryong , Park Se Hee , Park Kyeong Hye , Moon Ju Hyung , Kim Eui Hyun , Kim Sun Ho , Lee Eun Jig

Silent corticotroph adenomas (SCAs) are difficult to distinguish from other non-functioning pituitary adenomas (NFPAs) preoperatively. This study assessed the preoperative clinical parameters associated with SCAs. After excluding patients with increased 24-h urinary free cortisol, 341 patients who underwent surgery for NFPAs during 2011–2016 with available preoperative combined pituitary function test (CPFT) and immunohistochemical staining results were enrolled. The pati...